Hitoshi Nakazato

1.9k total citations
56 papers, 1.3k citations indexed

About

Hitoshi Nakazato is a scholar working on Nephrology, Molecular Biology and Physiology. According to data from OpenAlex, Hitoshi Nakazato has authored 56 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Nephrology, 20 papers in Molecular Biology and 10 papers in Physiology. Recurrent topics in Hitoshi Nakazato's work include Renal Diseases and Glomerulopathies (23 papers), Ion Transport and Channel Regulation (5 papers) and Chronic Kidney Disease and Diabetes (5 papers). Hitoshi Nakazato is often cited by papers focused on Renal Diseases and Glomerulopathies (23 papers), Ion Transport and Channel Regulation (5 papers) and Chronic Kidney Disease and Diabetes (5 papers). Hitoshi Nakazato collaborates with scholars based in Japan, United States and South Korea. Hitoshi Nakazato's co-authors include Ryuji Suzuki, Yuji Tsuruta, Hisashi Oku, Shoji Yamane, Tatsuya Horikawa, Koichi Nakanishi, Kazumoto Iijima, Masataka Honda, Norishige Yoshikawa and Kenji Ishikura and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Annals of Neurology.

In The Last Decade

Hitoshi Nakazato

51 papers receiving 1.3k citations

Peers

Countries citing papers authored by Hitoshi Nakazato

Since Specialization

Citations

This map shows the geographic impact of Hitoshi Nakazato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Nakazato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Nakazato more than expected).

Fields of papers citing papers by Hitoshi Nakazato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoshi Nakazato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Nakazato. The network helps show where Hitoshi Nakazato may publish in the future.

Co-authorship network of co-authors of Hitoshi Nakazato

This figure shows the co-authorship network connecting the top 25 collaborators of Hitoshi Nakazato. A scholar is included among the top collaborators of Hitoshi Nakazato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitoshi Nakazato. Hitoshi Nakazato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mycobacterium fortuitum Peritoneal Dialysis-Related Peritonitis in a Child: A Case Report 2024 ·SHILAP Revista de lepidopterología ·(unknown), Hiroshi Tamura, (unknown), (unknown), Hitoshi Nakazato	0
2	Three Pediatric Patients with Congenital Nephrogenic Diabetes Insipidus due to <i>AVPR2</i> Nonsense Mutations and Different Clinical Manifestations: A Case Report 2023 ·Case Reports in Nephrology and Dialysis ·(unknown), Hiroshi Tamura, (unknown), (unknown), Hitoshi Nakazato	0
3	Cyclosporine therapy could be considered for membranoproliferative glomerulonephritis with immunoglobulin A deposits: a case report 2022 ·BMC Nephrology ·Yuko Hidaka, Hiroshi Tamura, (unknown), (unknown), Hiroko Nagata, Hitoshi Nakazato	1
4	Predictors of hematoma as a complication in pediatric kidney biopsies 2022 ·Pediatrics International ·Hiroko Nagata, Hiroshi Tamura, Yuko Hidaka, Tokunori Ikeda, Hitoshi Nakazato	0
5	Epidemiology of biopsy-proven Henoch–Schönlein purpura nephritis in children: A nationwide survey in Japan 2022 ·PLoS ONE ·(unknown), Riku Hamada, Ichiro Tatsuno, Yuko Hamasaki, Yoshinori Araki, Yoshimitsu Gotoh, Koichi Nakanishi, Hitoshi Nakazato, Takeshi Matsuyama, Kazumoto Iijima, Norishige Yoshikawa, Tetsuji Kaneko, Shuichi Ito, Masataka Honda, Kenji Ishikura, (unknown)	11
6	Steroid therapy is effective for IgA nephropathy after liver transplantation in a pediatric patient 2021 ·SHILAP Revista de lepidopterología ·Hiroshi Tamura, (unknown), Hitoshi Nakazato	1
7	Tubulointerstitial nephritis and uveitis syndrome with concurrent macular edema caused by granulomatous uveitis 2020 ·SHILAP Revista de lepidopterología ·(unknown), Hiroshi Tamura, (unknown), Hitoshi Nakazato	3
8	Impact of the 2016 Kumamoto earthquake on patients with nephrogenic diabetes insipidus and preparations for the future 2020 ·SHILAP Revista de lepidopterología ·Hiroshi Tamura, Hiroko Nagata, (unknown), (unknown), Yuko Hidaka, Hitoshi Nakazato	1
9	High incidence of idiopathic nephrotic syndrome in East Asian children: a nationwide survey in Japan (JP-SHINE study) 2016 ·Clinical and Experimental Nephrology ·(unknown), (unknown), Kenji Ishikura, (unknown), Mai Sato, (unknown), Yuko Hamasaki, Satoshi Sasaki, Kazumoto Iijima, Norishige Yoshikawa, Koichi Nakanishi, Hitoshi Nakazato, Takeshi Matsuyama, Takashi Ando, Shuichi Ito, Masataka Honda	36
10	Two-Year Outcome of the ISKDC Regimen and Frequent-Relapsing Risk in Children with Idiopathic Nephrotic Syndrome 2013 ·Clinical Journal of the American Society of Nephrology ·Koichi Nakanishi, Kazumoto Iijima, Kenji Ishikura, Hiroshi Hataya, Hitoshi Nakazato, Satoshi Sasaki, Masataka Honda, Norishige Yoshikawa	38
11	2-Arylimino-5,6-dihydro-4H-1,3-thiazines as a new class of cannabinoid receptor agonists. Part 1: Discovery of CB2 receptor selective compounds 2007 ·Bioorganic & Medicinal Chemistry Letters ·Hiroyuki Kai, Yasuhide Morioka, (unknown), Koichi Morita, (unknown), Hitoshi Nakazato, Keiko Kawamoto, Kohji Hanasaki, (unknown), (unknown), (unknown), Kohji Abe, Hiroshi Okabe, (unknown), Takayoshi Yoshikawa, Hideyuki Takenaka	26
12	Genetics and clinical features of 15 Asian families with steroid-resistant nephrotic syndrome 2006 ·Nephrology Dialysis Transplantation ·Akiko Kitamura, Hiroyasu Tsukaguchi, Kazumoto Iijima, (unknown), Motoshi Hattori, Masahiro Ikeda, Masataka Honda, Kandai Nozu, Hitoshi Nakazato, Norishige Yoshikawa, Shoji Kagami, Masaaki Muramatsu, (unknown), Hae Il Cheong, Toshio Doi	16
13	In situ evaluation of podocin in normal and glomerular diseases 2003 ·Kidney International ·(unknown), Hitoshi Nakazato, Tomoyasu Kawano, Ken-ichi Iyama, (unknown), (unknown), Jiro Machida, (unknown), Fumio Endo, Shinzaburo Hattori	37
14	Pirfenidone suppresses tumor necrosis factor-α, enhances interleukin-10 and protects mice from endotoxic shock 2002 ·European Journal of Pharmacology ·Hisashi Oku, Hitoshi Nakazato, Tatsuya Horikawa, Yuji Tsuruta, Ryuji Suzuki	138
15	A novel anti-fibrotic agent pirfenidone suppresses tumor necrosis factor-α at the translational level 2002 ·European Journal of Pharmacology ·Hitoshi Nakazato, Hisashi Oku, Shoji Yamane, Yuji Tsuruta, Ryuji Suzuki	152
16	Suppression of murine endotoxic shock by sPLA2 inhibitor, indoxam, through group IIA sPLA2-independent mechanisms 1999 ·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Yasunori Yokota, Kohji Hanasaki, Takashi Ono, Hitoshi Nakazato, Tatsuo Kobayashi, Hitoshi Arita	63
17	Chloride channel CLCN5 mutations in Japanese children with familial idiopathic low molecular weight proteinuria 1999 ·Kidney International ·Hitoshi Nakazato, (unknown), (unknown), Shinichi Matsumoto, Fumio Endo, Ichiro Matsuda, Shinzaburo Hattori	19
18	Alkaline phosphatase expression in cultured endothelial cells of aorta and brain micro vessels: Induction by interleukin-6-type cytokines and suppression by transforming growth factor betas 1997 ·Life Sciences ·Hitoshi Nakazato, Masashi Deguchi, Masafumi Fujimoto, (unknown)	21
19	Splicing mutations in the COL4A5 gene in Alport's syndrome: Different mRNA expression between leukocytes and fibroblasts 1995 ·American Journal of Kidney Diseases ·Hitoshi Nakazato, Shinzaburo Hattori, (unknown), Toshinobu Matsuura, (unknown), (unknown), Fumio Endo, Ichiro Matsuda	5
20	[MLF syndrome (author's transl)]. 1977 ·PubMed ·Hitoshi Nakazato, E Satoyoshi	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact